Stelara’s Shift From Medicare B To D Was Costly, OIG Finds, How Much Will IRA Reforms Help?

 
• By Cathy Kelly
  
Stelara's Inclusion On the SAD List Drove a Big Increase In Part D Spending. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet